Spider Venom Contains Both Pain-Causing and Pain-Relieving Peptides — A Double-Edged Sword
Phoneutria nigriventer spider venom contains 7+ antinociceptive peptide toxins alongside pain-causing components, offering a rich source of non-opioid analgesic leads.
Quick Facts
What This Study Found
The pain caused by Phoneutria nigriventer venom is mediated through both peripheral and central mechanisms, involving B2 receptors, serotonin (5-HT4), glutamate (NMDA/AMPA), tachykinin (NK1/NK2), sodium channels (TTX-sensitive), acid-sensing channels (ASIC), and TRPV1 channels.
Despite the venom's pain-causing nature, seven individual toxins (omega-CNTX-Pn4a, omega-CNTX-Pn2a, omega-CNTX-Pn3a, kappa-CNTX-Pn1a, U7-CNTX-Pn1a, delta-CNTX-Pn1a, Gamma-CNTX-Pn1a) and a semi-synthetic peptide (PnPP-19) have shown consistent antinociceptive (pain-relieving) properties in experimental pain models.
The pain-relieving toxins work through mechanisms including calcium channel blockade, potassium channel activation, and modulation of opioid receptors.
Key Numbers
7 antinociceptive toxins + PnPP-19; pain via B2/5-HT4/NMDA/AMPA/NK1/NK2/ASIC/TRPV1; analgesia via Ca2+ channels, K+ channels, opioid receptors
How They Did This
This is a review article summarizing published research on the pro-nociceptive and antinociceptive properties of Phoneutria nigriventer venom and its isolated toxins. It covers in vitro mechanism studies and in vivo pain models.
Why This Research Matters
The opioid crisis has created urgent demand for non-opioid pain medicines. Spider venom toxins that block pain through novel mechanisms could lead to new analgesics without the addiction risk of opioids.
The fact that multiple pain-relieving peptides exist in a single venom source provides several drug leads to pursue simultaneously.
The Bigger Picture
The opioid crisis demands non-opioid pain medications. Spider venom toxins that block pain through novel mechanisms could provide leads for new analgesics without addiction risk. Evolution has optimized these molecules over millions of years.
What This Study Doesn't Tell Us
This is a review article. The antinociceptive peptides have been tested in animal models but have not entered human clinical trials. Translating venom peptides into safe human medications involves significant challenges including stability, delivery, and side effects.
Some mechanisms described are based on limited studies that need replication.
Questions This Raises
- ?Which venom-derived peptide is closest to clinical development?
- ?Can these analgesic peptides be synthesized economically?
- ?Do they cause tolerance with repeated use like opioids?
Trust & Context
- Key Stat:
- 7+ analgesic peptides in one spider venom, targeting calcium channels, potassium channels, and opioid receptors — diverse non-opioid pain mechanisms
- Evidence Grade:
- Review-level evidence. Individual toxins have been tested in animal pain models but none have reached human clinical trials.
- Study Age:
- Published in 2020. Venom-derived analgesic research continues alongside the urgent need for non-opioid pain medications.
- Original Title:
- Pain modulatory properties of Phoneutria nigriventer crude venom and derived peptides: A double-edged sword.
- Published In:
- Toxicon : official journal of the International Society on Toxinology, 185, 120-128 (2020)
- Database ID:
- RPEP-04924
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How can something that causes pain also relieve it?
Spider venom is a complex cocktail of hundreds of toxins. Some activate pain receptors (causing the spider bite to hurt), while others block different pain pathways. The pain-blocking peptides can be isolated and developed separately as medicines.
Are venom-based drugs realistic?
Yes — several approved drugs come from venoms. Ziconotide (from cone snail venom) treats severe pain. The spider venom peptides target different pain mechanisms and could lead to new non-addictive painkillers.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04924APA
Lauria, Pedro Santana Sales; Villarreal, Cristiane Flora; Casais-E-Silva, Luciana Lyra. (2020). Pain modulatory properties of Phoneutria nigriventer crude venom and derived peptides: A double-edged sword.. Toxicon : official journal of the International Society on Toxinology, 185, 120-128. https://doi.org/10.1016/j.toxicon.2020.07.005
MLA
Lauria, Pedro Santana Sales, et al. "Pain modulatory properties of Phoneutria nigriventer crude venom and derived peptides: A double-edged sword.." Toxicon : official journal of the International Society on Toxinology, 2020. https://doi.org/10.1016/j.toxicon.2020.07.005
RethinkPeptides
RethinkPeptides Research Database. "Pain modulatory properties of Phoneutria nigriventer crude v..." RPEP-04924. Retrieved from https://rethinkpeptides.com/research/lauria-2020-pain-modulatory-properties-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.